SuviCa Inc.
The University of Colorado Connection
is a ÂÌñ»»ÆÞ start-up cofounded by (ÂÌñ»»ÆÞ Molecular, Cellular & Developmental Biology) focused on the discovery and development of small molecule cancer therapeutics targeting a unique mechanism of action.ÌýBased on the compelling efficacy and safety profiles of SuViCa’s lead drug candidate, SVC112, SuViCa has entered the competitive National Cancer Institute Experimental Therapeutics (NExT) Program to develop SVC112 for salivary gland cancer (SGC). SVC112 has been developed in collaboration between Tin Tin Su and Antonio Jimeno (), and further development of SVC112 is being supported by the Anschutz Acceleration Initiative.
Funding Status and Investment Opportunities
- Industry Applications: Health and Wellness, Biotech​​, Therapeutics
- Funding Round: Seed
- Contact for Investment Inquiries: Tin Tin Su, tin.su@Colorado.edu
In the News
Venture Partners Programs​
- Destination Startup (2024)
- Lab Venture ChallengeÌý(2018)
- Intellectual Property Management (2003)
Technology Development Funding
U.S. National Institutes of Health (NIH)
ÌýÌý ÌýThis page was last updated on April 13, 2026. Please email vpnews@colorado.edu for corrections or updates
The Insider Investor eNewsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard,Ìýsenior marketing and communications specialist for Venture Partners at ÂÌñ»»ÆÞ.
For media inquiries, please visit .